These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 101589)

  • 1. Relation of the urinary cancer-related glycoprotein EDC1 to plasma inter-alpha-trypsin inhibitor.
    Chawla RK; Wadsworth AD; Rudman D
    J Immunol; 1978 Nov; 121(5):1636-9. PubMed ID: 101589
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of plasma inter-alpha trypsin inhibitor and cancer-related glycoprotein EDC1 on phytohemagglutinin-induced thymidine uptake in lymphocytes.
    Chawla RK; Lawson DH; Richmond A; Rudman D
    Cancer Res; 1980 Nov; 40(11):4187-91. PubMed ID: 6162547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitryptic property of cancer-related glycoprotein EDC1.
    Chawla RK; Wadsworth AD; Rudman D
    Cancer Res; 1978 Feb; 38(2):452-7. PubMed ID: 145894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-related urinary proteinase inhibitor, EDC1: a new method for its isolation and evidence for multiple forms.
    Chawla RK; Lawson DH; Ahmad M; Travis J
    J Cell Biochem; 1992 Nov; 50(3):227-36. PubMed ID: 1469060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma inter-alpha-trypsin inhibitor-related urinary glycoprotein EDC1 inhibits the growth of a Burkitt's lymphoma cell line.
    Chawla RK; Lawson DH; Travis J
    J Cell Biochem; 1990 Apr; 42(4):207-17. PubMed ID: 1692840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A system of cancer-related urinary glycoproteins: biochemical properties and clinical applications.
    Rudman D; Chawla RK; Wadsworth AD; Nixon DW; Schwartz M
    Trans Assoc Am Physicians; 1977; 90():286-99. PubMed ID: 77073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and some properties of a plasma protein which reacts with an antiserum against urinary trypsin inhibitor-1.
    Maehara S; Kawashita E; Sumi H; Toki N
    Scand J Clin Lab Invest; 1983 Feb; 43(1):21-6. PubMed ID: 6194553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary cancer-related protein EDC1 and serum inter-alpha trypsin inhibitor in breast cancer.
    Chawla RK; Miller FW; Lawson DH; Nixon DW
    Tumour Biol; 1984; 5(6):351-63. PubMed ID: 6085600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a novel glycoprotein (EDC1) from the urine of a patient with acute myelocytic leukemia.
    Rudman D; Chawla RK; Hendrickson LJ; Vogler WR; Sophianopoulos AJ
    Cancer Res; 1976 May; 36(5):1837-46. PubMed ID: 57827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigens of erythrocyte membranes.
    Nery R; Bullman H; Barsoum AL
    Nat New Biol; 1973 Nov; 246(150):44-6. PubMed ID: 4128113
    [No Abstract]   [Full Text] [Related]  

  • 11. The specific proteinuria of cancer patients.
    Rudman D; Chawla RK; Nixon DW
    Trans Assoc Am Physicians; 1978; 91():229-41. PubMed ID: 754392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of the structure and clinical role of the carcinoembryonic antigen (CEA) and related macromolecules with particular reference to urothelial carcinoma.
    Neville AM; Nery R; Hall RR; Turberville C; Laurence DJ
    Br J Cancer Suppl; 1973 Aug; 1():198-207. PubMed ID: 4216361
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal profile of serum proteinase inhibitors in cancer patients.
    Chawla RK; Rausch DJ; Miller FW; Vogler WR; Lawson DH
    Cancer Res; 1984 Jun; 44(6):2718-23. PubMed ID: 6722803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men.
    Marengo SR; Resnick MI; Yang L; Chung JY
    J Urol; 1998 May; 159(5):1444-50. PubMed ID: 9554330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.
    Langkilde NC; Wolf H; Clausen H; Orntoft TF
    Cancer Res; 1992 Sep; 52(18):5030-6. PubMed ID: 1516058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic relationship between the human bronchial mucus inhibitor and plasma inter-alpha-trypsin inhibitor.
    Hochstrasser K; Reichert R; Heimburger N
    Hoppe Seylers Z Physiol Chem; 1973 May; 354(5):587-8. PubMed ID: 4547735
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunochemical determination of the serum protein reacting with antibody against human urinary trypsin inhibitor by single radial immunodiffusion: use of polyethylene glycol.
    Maehara S; Kawashita E; Himeno Y; Ishibe T; Toki N; Sumi H; Tanaka Y; Sasaki K
    J Immunol Methods; 1985 Jun; 80(1):117-23. PubMed ID: 3925017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunological quantitation of the urinary trypsin inhibitor in normal blood and urine.
    Jönsson-Berling BM; Ohlsson K; Rosengren M
    Biol Chem Hoppe Seyler; 1989 Nov; 370(11):1157-61. PubMed ID: 2482040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human urinary trypsin inhibitor. III. Investigation of plasma protein which reacts with an antiserum against urinary trypsin inhibitor].
    Maehara S
    Nihon Hinyokika Gakkai Zasshi; 1983 Sep; 74(9):1653-60. PubMed ID: 6676591
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of urinary trypsin inhibitor in urine, plasma and cancer tissues of patients with stomach cancer.
    Nishino N; Aoki K; Tokura Y; Sakaguchi S; Fujie M; Sugawara Y; Takada Y; Takada A
    Haemostasis; 1989; 19(2):112-9. PubMed ID: 2471673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.